Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography.

about

Value analysis of digital breast tomosynthesis for breast cancer screening in a commercially-insured US population.Using semi-Markov processes to study timeliness and tests used in the diagnostic evaluation of suspected breast cancer.

P2860

Q34977434-29D4DE7C-B9C8-4ED3-8025-63BF5CBB5DC7 Q40495769-E493BA9B-BA82-4923-89A5-9454BCE93551

P2860

Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography.

Item

http://www.wikidata.org/entity/Q36806768

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Diagnostic imaging and biopsy ...... digital screening mammography.

@ast

Diagnostic imaging and biopsy ...... digital screening mammography.

@en

type

Item

label

Diagnostic imaging and biopsy ...... digital screening mammography.

@ast

Diagnostic imaging and biopsy ...... digital screening mammography.

@en

prefLabel

Diagnostic imaging and biopsy ...... digital screening mammography.

@ast

Diagnostic imaging and biopsy ...... digital screening mammography.

@en

P1476

Diagnostic imaging and biopsy ...... digital screening mammography.

@en

P2093

Alison Sweet

http://www.w3.org/2001/XMLSchema#string

Brian L Sprague

http://www.w3.org/2001/XMLSchema#string

David Lee

http://www.w3.org/2001/XMLSchema#string

Diana S M Buist

http://www.w3.org/2001/XMLSchema#string

Leah Karliner

http://www.w3.org/2001/XMLSchema#string

Louise Henderson

http://www.w3.org/2001/XMLSchema#string

Rebecca A Hubbard

http://www.w3.org/2001/XMLSchema#string

Ruslan Horblyuk

http://www.w3.org/2001/XMLSchema#string

Tracy Onega

http://www.w3.org/2001/XMLSchema#string

Weiwei Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Screening for breast cancer: an update for the U.S. Preventive Services Task Force

Quantitative assessment of percent breast density: analog versus digital acquisition.

Cost of breast-related care in the year following false positive screening mammograms.

Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force.

Timeliness of follow-up after abnormal screening mammogram: variability of facilities.

The randomized trials of breast cancer screening: what have we learned?

Comparison of recall and cancer detection rates for immediate versus batch interpretation of screening mammograms.

Performance benchmarks for diagnostic mammography.

Effects of digital mammography uptake on downstream breast-related care among older women.

Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk

P2888

s10549-013-2466-5

P304

879-887

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-013-2466-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23471650

http://www.w3.org/2001/XMLSchema#string

P932

3640408

http://www.w3.org/2001/XMLSchema#string

Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography.

about

P2860

P2860

Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932